Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HistoSonics
MedTech
HistoSonics reels in $250M in funding months after sale
Cancer treatment developer HistoSonics reeled in $250 million in a series D round of financing two months after it sold to a group for $2.5 billion.
Joseph Keenan
Oct 20, 2025 9:10am
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
HistoSonics considering a sale to major medtechs: report
May 2, 2025 11:30am
HistoSonics nets $102M for sound-powered liver cancer therapy
Aug 15, 2024 12:45pm
HistoSonics nets de novo nod for liver tumor-blasting ultrasound
Oct 9, 2023 3:00pm
Fierce Medtech's 2022 Fierce 15
Mar 20, 2023 3:00am
